Ondine Biomedical Inc (OBI) — Net Asset Quality Index
Ondine Biomedical Inc (OBI) has a Net Asset Quality Index of 24.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX14.40 Million minus total liabilities of GBX10.91 Million yields net assets of GBX3.49 Million. A higher index indicates a stronger, lower-leverage balance sheet. See how many days can Ondine Biomedical Inc fund operations to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ondine Biomedical Inc Net Asset Quality Index Over Time (2001–2025)
This chart shows how Ondine Biomedical Inc's Net Asset Quality Index has evolved across 18 annual periods from 2001 to 2025. As of December 2025, the index stands at 24.2%, representing net assets of GBX3.49 Million against total assets of GBX14.40 Million GBX. Explore Ondine Biomedical Inc (OBI) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Ondine Biomedical Inc (2001–2025)
The table below presents the year-by-year Net Asset Quality Index for Ondine Biomedical Inc from 2001 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Ondine Biomedical Inc market capitalisation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 24.2% | GBX3.49 Million | GBX14.40 Million | GBX10.91 Million | ▼ -29.4 pp |
| 2024 | 53.6% | GBX6.88 Million | GBX12.82 Million | GBX5.95 Million | ▲ +17.3 pp |
| 2023 | 36.4% | GBX2.08 Million | GBX5.73 Million | GBX3.65 Million | ▼ -33.9 pp |
| 2022 | 70.3% | GBX11.64 Million | GBX16.57 Million | GBX4.92 Million | ▼ -16.6 pp |
| 2021 | 86.9% | GBX29.66 Million | GBX34.14 Million | GBX4.48 Million | ▲ +1370.7 pp |
| 2020 | -1283.8% | GBX-33.83 Million | GBX2.63 Million | GBX36.46 Million | ▼ -388.7 pp |
| 2019 | -895.1% | GBX-26.07 Million | GBX2.91 Million | GBX28.99 Million | ▼ -497.1 pp |
| 2018 | -397.9% | GBX-17.90 Million | GBX4.50 Million | GBX22.40 Million | ▼ -281.1 pp |
| 2017 | -116.8% | GBX-6.55 Million | GBX5.61 Million | GBX12.16 Million | ▼ -127.8 pp |
| 2010 | 11.0% | GBX279.19K | GBX2.53 Million | GBX2.25 Million | ▼ -37.8 pp |
| 2009 | 48.8% | GBX1.28 Million | GBX2.62 Million | GBX1.34 Million | ▲ +3.4 pp |
| 2008 | 45.4% | GBX1.34 Million | GBX2.95 Million | GBX1.61 Million | ▼ -38.0 pp |
| 2007 | 83.4% | GBX10.84 Million | GBX13.00 Million | GBX2.16 Million | ▼ -6.5 pp |
| 2006 | 89.9% | GBX16.59 Million | GBX18.46 Million | GBX1.87 Million | ▼ -5.8 pp |
| 2005 | 95.7% | GBX16.50 Million | GBX17.25 Million | GBX745.61K | ▲ +3672.4 pp |
| 2003 | -3576.7% | GBX-227.62K | GBX6.36K | GBX233.99K | ▲ +13319.5 pp |
| 2002 | -16896.2% | GBX-143.28K | GBX848.00 | GBX144.13K | ▼ -16992.2 pp |
| 2001 | 96.0% | GBX1.39 Million | GBX1.45 Million | GBX58.02K | — |